Cargando…
A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin(®)) as a Resuscitative Agent in Hypovolemic Shock Patients
INTRODUCTION: Centhaquine (Lyfaquin(®)) showed significant safety and efficacy in preclinical and clinical phase I and II studies. METHODS: A prospective, multicentric, randomized phase III study was conducted in patients with hypovolemic shock, systolic blood pressure (SBP) ≤ 90 mmHg, and blood lac...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167383/ https://www.ncbi.nlm.nih.gov/pubmed/34061314 http://dx.doi.org/10.1007/s40265-021-01547-5 |